Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Ly9em1flox/Cya
Common Name:
Ly9-flox
Product ID:
S-CKO-19242
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Ly9-flox
Strain ID
CKOCMP-17085-Ly9-B6J-VA
Gene Name
Ly9
Product ID
S-CKO-19242
Gene Alias
CD229; Lgp100; Ly-9; SLAMF3; T100
Background
C57BL/6JCya
NCBI ID
17085
Modification
Conditional knockout
Chromosome
1
Phenotype
MGI:96885
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Ly9em1flox/Cya mice (Catalog S-CKO-19242) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000068878
NCBI RefSeq
NM_008534
Target Region
Exon 3~5
Size of Effective Region
~3.9 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Ly9, also known as CD229 and SLAMF3, is a homophilic receptor belonging to the signaling lymphocytic activation molecule family (SLAMF). It is predominantly expressed on B and T cells, acting as a cosignaling molecule to regulate lymphocyte homeostasis and activation, thus playing crucial roles in innate and adaptive immune responses [1,3].

Ly9 -/- mouse models have revealed multiple functions of Ly9. In iNKT cell development, Ly9 is a non-redundant negative regulator. Ly9-deficient mice on a BALB/c background had an expanded thymic NKT2 cell population and nearly absent NKT1 cells in the thymus, while the number of peripheral NKT1 cells was comparable to wild-type mice, indicating distinct homeostatic requirements for different iNKT cell subsets depending on tissue localization. Also, anti-Ly9 treatment in wild-type mice impaired cytokine production and reduced spleen iNKT cell numbers [2]. In SjS-like disease model (NOD.H-2h4 mice), anti-Ly9 antibody treatment depleted key lymphocyte subsets (MZ, B1, and germinal center B cells) involved in SjS pathology without general immunosuppression, reduced salivary gland lymphocyte infiltration, and decreased anti-nuclear autoantibody levels, suggesting Ly9 as a potential therapeutic target for SjS [4]. Ly9-deficient mice spontaneously developed features of systemic autoimmunity like autoantibody production, and in aged mice, key autoimmunity-related cell subsets were expanded. In vitro, Ly9 acts as an inhibitory receptor of IFN-γ producing CD4(+) T cells [5]. Ly9 -/- T cells show a mild Th2 defect with reduced IL-4 production and poor proliferation and little IL-2 production after suboptimal stimulation, differentiating them from SLAM -/- and SAP -/- mice [6].

In conclusion, Ly9 plays essential roles in lymphocyte homeostasis, iNKT cell development, and the prevention of autoimmunity. Studies using Ly9 -/- mouse models have provided insights into its functions in diseases such as SjS and systemic autoimmunity, highlighting its potential as a therapeutic target in these disease areas.

References:
1. Angulo, Ana, Cuenca, Marta, Martínez-Vicente, Pablo, Engel, Pablo. 2019. Viral CD229 (Ly9) homologs as new manipulators of host immunity. In Journal of leukocyte biology, 105, 947-954. doi:10.1002/JLB.2MR1018-413R. https://pubmed.ncbi.nlm.nih.gov/30791129/
2. Cuenca, Marta, Puñet-Ortiz, Joan, Ruart, Maria, Terhorst, Cox, Engel, Pablo. 2017. Ly9 (SLAMF3) receptor differentially regulates iNKT cell development and activation in mice. In European journal of immunology, 48, 99-105. doi:10.1002/eji.201746925. https://pubmed.ncbi.nlm.nih.gov/28980301/
3. Roncador, Giovanna, Puñet-Ortiz, Joan, Maestre, Lorena, Fernández de Larrea, Carlos, Engel, Pablo. 2022. CD229 (Ly9) a Novel Biomarker for B-Cell Malignancies and Multiple Myeloma. In Cancers, 14, . doi:10.3390/cancers14092154. https://pubmed.ncbi.nlm.nih.gov/35565280/
4. Puñet-Ortiz, Joan, Sáez Moya, Manuel, Cuenca, Marta, Lazaro, Adriana, Engel, Pablo. 2018. Ly9 (CD229) Antibody Targeting Depletes Marginal Zone and Germinal Center B Cells in Lymphoid Tissues and Reduces Salivary Gland Inflammation in a Mouse Model of Sjögren's Syndrome. In Frontiers in immunology, 9, 2661. doi:10.3389/fimmu.2018.02661. https://pubmed.ncbi.nlm.nih.gov/30519241/
5. de Salort, Jose, Cuenca, Marta, Terhorst, Cox, Engel, Pablo, Romero, Xavier. 2013. Ly9 (CD229) Cell-Surface Receptor is Crucial for the Development of Spontaneous Autoantibody Production to Nuclear Antigens. In Frontiers in immunology, 4, 225. doi:10.3389/fimmu.2013.00225. https://pubmed.ncbi.nlm.nih.gov/23914190/
6. Graham, Daniel B, Bell, Michael P, McCausland, Megan M, Crotty, Shane, McKean, David J. . Ly9 (CD229)-deficient mice exhibit T cell defects yet do not share several phenotypic characteristics associated with SLAM- and SAP-deficient mice. In Journal of immunology (Baltimore, Md. : 1950), 176, 291-300. doi:. https://pubmed.ncbi.nlm.nih.gov/16365421/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest